In 2023, blood and blood forming organs medicine sales in Japan were estimated at $50.1 US Dollars PPP per capita. Forecasted data suggests a steady increase from 2024 to 2028, highlighting an annual growth of approximately 1.8% to 1.7% year-on-year. The compound annual growth rate (CAGR) from 2024 to 2028 is projected to be around 1.7%.

Future trends to watch for include:

Aging population in Japan, driving increased demand for blood and blood forming organ medicines.
Advancements in biotechnology potentially introducing innovative therapies.
Regulatory changes impacting market access and pricing strategies.
Global supply chain dynamics influencing domestic availability and cost of medicines.